Melbourne Clinical Trials
The Patch Study
The study drug is exploring a potential new treatment type for high blood pressure.
4 sets of 3-night stays nights
17 visits
This study is an evaluation of a potential new treatment for pulmonary arterial hypertension (PAH). PAH is a rare, progressive disorder that most commonly affects women aged 30-60. It causes high blood pressure in the arteries of the lungs, leading to symptoms like shortness of breath, fatigue, and chest pain.
Call us on 1300 576 085 to discuss your eligibility today!
Eligibility
Biological Sex Females
Ethnicity Caucasian with light/pale skin
Age 18-55 years old
BMI 18.5 - 32kg/m²
Weight Between 58-77kg
Medical History No significant medical history
Medication Not taking any prescription medication
Smoking History Non-smokers or smoking less than 2 cigarettes per day